Central Precocious Puberty
📧 Sign up to get email alerts when something new happens for Central Precocious Puberty.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty [Phase 3]
A Phase 3 clinical trial assessing efficacy, safety, and pharmacokinetics of leuprolide mesylate in children with central precocious puberty…
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial) [Phase 3]
A Phase 3 pediatric trial evaluating the efficacy, safety, and pharmacokinetics of Debio 4326 for central precocious puberty is currently AC…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial) [Phase 3]
Phase 3 study assessing the efficacy, safety, and pharmacokinetics of Debio 4326 in pediatric participants with central precocious puberty; …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Spexin and Phoenixin-20 in Girls With Central Precocious Puberty
A completed clinical trial evaluating spexin and phoenixin-20 in girls with Central Precocious Puberty.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China
This is a completed study analyzing medical records of children with central precocious puberty in China, sponsored by Takeda.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty [Phase 4]
Phase 4 study of leuprolide acetate depot in children with central precocious puberty has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty [Phase 3]
Phase 3 trial evaluating the efficacy, safety, and pharmacokinetics of leuprolide mesylate in children with Central precocious puberty.
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty [Phase 4]
A Phase 4 clinical trial evaluates the efficacy and safety of Leuprolide Acetate 45 mg in subjects with Central precocious puberty. The stud…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Diagnostic Power of Basal LH Compared to Peak LH After Stimulus Test in the Diagnosis of Central Precocious Puberty
The study evaluated whether basal luteinizing hormone (LH) can diagnose central precocious puberty as effectively as the peak LH after a sti…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty. [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of a 3-month formulation of triptorelin in Chinese children with central precocious puber…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty. [Phase 3]
A Phase 3 study evaluating the efficacy and safety of a 6-month formulation of triptorelin in pediatric patients with Central Precocious Pub…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Evaluate the Efficacy and Safety of DWJ108J [Phase 3]
A Phase 3 clinical trial update for DWJ108J in Central Precocious Puberty is listed, with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP) [Phase 3]
Phase 3 study evaluating Leuprolide acetate 45 mg, a 6-month formulation, in children with central precocious puberty has completed and resu…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Histrelin Subcutaneous Implant in Children With Central Precocious Puberty [Phase 3]
Phase 3 trial update for a histrelin subcutaneous implant in children with central precocious puberty, results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls [Phase 3]
Phase 3 clinical trial validating the triptorelin test for diagnosing central precocious puberty in girls has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty [Phase 4]
A Phase 4 clinical trial update on Leuprorelin acetate DPS (Leuplin DPS) for monthly/quarterly treatment in central precocious puberty has c…
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty [Phase 3]
Phase 3 trial update for leuprolide acetate injectable suspension in central precocious puberty has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants
A completed clinical trial evaluating the safety and efficacy of Enantone (leuprorelin) in Chinese participants with central precocious pube…
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants [Phase 4]
Phase 4 trial assessing safety and efficacy of leuprorelin in Chinese participants with central precocious puberty has completed and results…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate [Phase 4]
A Phase 4 clinical trial analysis examines body mass index in patients with central precocious puberty treated with leuprolide acetate.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty [Phase 4]
This update notes the completion of a Phase 4 clinical trial evaluating comprehensive diagnosis and treatment for central precocious puberty…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty [Phase 3]
This Phase 3 trial evaluates the efficacy, safety, and pharmacokinetics of a six-month formulation of triptorelin in children with central p…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of Luphere Depot Inj. 3.75mg (leuprolide acetate) in central precocious puberty has compl…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty [Phase 3]
A completed Phase 3 safety-extension trial evaluated leuprolide acetate (Lupron Depot) for central precocious puberty, with results posted i…
-
CLINICAL_TRIALS trial_result · 2011-02-09Clinical Trial Update: A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty [Phase 3]
This update reports the completion of a Phase 3 trial evaluating two quarterly dosing regimens of leuprolide (11.25 mg and 30 mg) for centra…